Compass Therapeutics Inc (CMPX) Ownership

$0.69

$0.01 (1.43%)
Last update: 02:08 PM EST
Day's range
$0.64
Day's range
$0.73

Compass Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
TANG CAPITAL MANAGEMENT LLC 11/16/2026 17.99 M $18.71 M   0.00% 9.63%
ORBIMED ADVISORS LLC 11/16/2026 15.22 M $15.83 M   0.00% 8.15%
MONTANOVA CAPITAL, LLC 11/16/2026 14.33 M $14.90 M   1.60% 7.67%
BLACKROCK, INC. 11/13/2026 11.39 M $11.85 M   1.00% 6.10%
ENAVATE SCIENCES GP, LLC 11/16/2026 7.79 M $8.10 M   0.00% 4.17%
STATE STREET CORP 11/12/2026 7.74 M $8.05 M   -22.26% 4.14%
PALO ALTO INVESTORS LP 11/16/2026 7.15 M $7.43 M   22.58% 3.83%
VANGUARD CAPITAL MANAGEMENT LLC 11/13/2026 5.99 M $6.23 M   -2.03% 3.21%
MILLENNIUM MANAGEMENT LLC 11/16/2026 4.69 M $4.87 M   -0.57% 2.51%
QUBE RESEARCH & TECHNOLOGIES LTD 11/13/2026 4.17 M $4.34 M   13.11% 2.23%
GEODE CAPITAL MANAGEMENT, LLC 11/06/2026 3.64 M $3.79 M   -4.48% 1.95%
ROCK SPRINGS CAPITAL MANAGEMENT LP 11/16/2026 3.52 M $3.67 M   0.00% 1.89%
VIVO CAPITAL, LLC 11/13/2026 3.42 M $3.56 M   -55.87% 1.83%
GOLDMAN SACHS GROUP INC 11/16/2026 3.39 M $3.53 M   -3.86% 1.82%
BLUE OWL CAPITAL HOLDINGS LP 11/13/2026 3.15 M $3.28 M   -12.97% 1.69%
HRT FINANCIAL LP 11/13/2026 2.66 M $2.77 M   1,465.17% 1.43%
ACADIAN ASSET MANAGEMENT LLC 11/09/2026 2.64 M $2.73 M   126.97% 1.41%
CITADEL ADVISORS LLC 11/16/2026 2.14 M $2.22 M   -40.12% 1.14%
VANGUARD PORTFOLIO MANAGEMENT LLC 11/13/2026 2.08 M $2.16 M   -44.90% 1.11%
ALLY BRIDGE GROUP (NY) LLC 11/16/2026 2.00 M $2.08 M   100.00% 1.07%
AQR CAPITAL MANAGEMENT LLC 11/16/2026 1.98 M $2.05 M   -43.71% 1.06%
FISHER ASSET MANAGEMENT, LLC 11/06/2026 1.95 M $2.02 M   39.80% 1.04%
FMR LLC 11/10/2026 1.80 M $1.87 M   48.27% 0.96%
D. E. SHAW & CO., INC. 11/16/2026 1.75 M $1.82 M   753.98% 0.93%
MARSHALL WACE, LLP 11/13/2026 1.71 M $1.78 M   409.82% 0.91%
BIRCHVIEW CAPITAL, LP 11/13/2026 1.58 M $1.64 M   -5.97% 0.84%
MORGAN STANLEY 11/13/2026 1.49 M $1.55 M   103.30% 0.80%
ALGERT GLOBAL LLC 11/17/2026 1.46 M $1.52 M   373.30% 0.78%
SQUAREPOINT OPS LLC 11/09/2026 1.39 M $1.45 M   37.94% 0.74%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 11/13/2026 1.21 M $1.26 M   100.00% 0.65%
NORTHERN TRUST CORP 11/16/2026 1.09 M $1.13 M   -4.53% 0.58%
CAPTION MANAGEMENT, LLC 11/16/2026 1.00 M $1.04 M   100.00% 0.54%
VANGUARD FIDUCIARY TRUST CO 11/13/2026 973.19 K $1.01 M   -2.77% 0.52%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/16/2026 901.30 K $937.35 K   1,503.74% 0.48%
ROYCE & ASSOCIATES LP 11/09/2026 888.39 K $923.93 K   -33.54% 0.48%
DIMENSIONAL FUND ADVISORS LP 11/04/2026 855.72 K $890.77 K   58.12% 0.46%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/16/2026 775.92 K $806.96 K   151.68% 0.42%
KVP CAPITAL ADVISORS, LP 11/16/2026 771.00 K $801.84 K   0.00% 0.41%
TWO SIGMA INVESTMENTS, LP 11/16/2026 769.44 K $800.22 K   140.22% 0.41%
CM MANAGEMENT, LLC 11/12/2026 750.00 K $780.00 K   36.36% 0.40%
BURKEHILL GLOBAL MANAGEMENT, LP 11/16/2026 700.00 K $728.00 K   0.00% 0.37%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 11/10/2026 677.25 K $704.34 K   29.30% 0.36%
QUADRATURE CAPITAL LTD 11/13/2026 638.82 K $664.37 K   490.13% 0.34%
CITIGROUP INC 11/04/2026 615.14 K $639.74 K   -13.84% 0.33%
EXOME ASSET MANAGEMENT LLC 11/16/2026 511.08 K $531.53 K   85.06% 0.27%
WALLEYE CAPITAL LLC 11/13/2026 492.91 K $512.63 K   100.00% 0.26%
BANK OF AMERICA CORP /DE/ 11/16/2026 464.38 K $482.96 K   -18.09% 0.25%
WELLINGTON MANAGEMENT GROUP LLP 11/16/2026 459.04 K $477.40 K   21.22% 0.25%
JACOBS LEVY EQUITY MANAGEMENT, INC 11/16/2026 449.30 K $467.27 K   100.00% 0.24%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/16/2026 430.89 K $448.13 K   42.14% 0.23%

Compass Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 239 institutional investors and hedge funds held shares of Compass Therapeutics Inc. The most heavily invested institutionals were:

TANG CAPITAL MANAGEMENT LLC: 17.99 M

ORBIMED ADVISORS LLC: 15.22 M

MONTANOVA CAPITAL, LLC: 14.33 M

BlackRock, Inc.: 11.39 M

Enavate Sciences GP, LLC: 7.79 M

STATE STREET CORP: 7.74 M

85.86% of Compass Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 179.97 M shares in the last 24 months. This purchase volume represents approximately $122.38 M in transactions.